Eledon Presents Phase 2 BESTOW Trial Data at Kidney Week
Eledon Pharmaceuticals presented Phase 2 BESTOW trial data on tegoprubart compared with tacrolimus, reporting sustained improvements in quality of life and symptom burden.
Eledon Pharmaceuticals presented Phase 2 BESTOW trial data on tegoprubart compared with tacrolimus, reporting sustained improvements in quality of life and symptom burden.